Next generation sequencing reveals the antibiotic resistant variants in the genome of Pseudomonas aeruginosa
暂无分享,去创建一个
S. Sekaran | R. Razali | C. Le | Ranganath Gudimella | R. Manikam | Babu Ramanathan | H. Jindal | A. Anwar | Johan Poole-Johnson
[1] G. Zúñiga,et al. Identification of extensive drug resistant Pseudomonas aeruginosa strains: New clone ST1725 and high-risk clone ST233 , 2017, PloS one.
[2] R. Eils,et al. Complex heatmaps reveal patterns and correlations in multidimensional genomic data , 2016, Bioinform..
[3] P. Rosenstiel,et al. Association between clinical antibiotic resistance and susceptibility of Pseudomonas in the cystic fibrosis lung , 2016, Evolution, medicine, and public health.
[4] G. Raman,et al. Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis , 2014, Antimicrobial Resistance and Infection Control.
[5] J. Lalucat,et al. Genome Analysis of Environmental and Clinical P. aeruginosa Isolates from Sequence Type-1146 , 2014, PloS one.
[6] G. Delgado,et al. Pseudomonas aeruginosa clinical and environmental isolates constitute a single population with high phenotypic diversity , 2014, BMC Genomics.
[7] Lori A. S. Snyder,et al. Epidemiological investigation of Pseudomonas aeruginosa isolates from a six-year-long hospital outbreak using high-throughput whole genome sequencing. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[8] N. Loman,et al. Clusters of genetically similar isolates of Pseudomonas aeruginosa from multiple hospitals in the UK. , 2013, Journal of medical microbiology.
[9] A. Friedrich,et al. Overview of molecular typing methods for outbreak detection and epidemiological surveillance. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[10] Sergey I. Nikolenko,et al. SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing , 2012, J. Comput. Biol..
[11] D. Fisher,et al. The impact of multidrug resistance in healthcare-associated and nosocomial Gram-negative bacteraemia on mortality and length of stay: cohort study. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[12] J. Michiels,et al. Phenotypic and Genome-Wide Analysis of an Antibiotic-Resistant Small Colony Variant (SCV) of Pseudomonas aeruginosa , 2011, PloS one.
[13] Jian Yang,et al. VFDB 2012 update: toward the genetic diversity and molecular evolution of bacterial virulence factors , 2011, Nucleic Acids Res..
[14] Nicola K. Petty,et al. BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons , 2011, BMC Genomics.
[15] J. Weingarten,et al. Pneumonia due to Pseudomonas aeruginosa: part I: epidemiology, clinical diagnosis, and source. , 2011, Chest.
[16] Robert A. Edwards,et al. Quality control and preprocessing of metagenomic datasets , 2011, Bioinform..
[17] M. Kaufmann,et al. Evaluation of a nine-locus variable-number tandem-repeat scheme for typing of Pseudomonas aeruginosa. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[18] G. Weinstock,et al. High-throughput whole-genome sequencing to dissect the epidemiology of Acinetobacter baumannii isolates from a hospital outbreak. , 2010, The Journal of hospital infection.
[19] Nancy D. Hanson,et al. Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms , 2009, Clinical Microbiology Reviews.
[20] E. Septimus,et al. Clinical Challenges in Addressing Resistance to Antimicrobial Drugs in the Twenty‐First Century , 2009, Clinical pharmacology and therapeutics.
[21] C. Di Serio,et al. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. , 2009, American journal of respiratory and critical care medicine.
[22] Cole Trapnell,et al. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.
[23] R. Hancock,et al. Regulation of virulence and antibiotic resistance by two-component regulatory systems in Pseudomonas aeruginosa. , 2009, FEMS microbiology reviews.
[24] Rick L. Stevens,et al. The RAST Server: Rapid Annotations using Subsystems Technology , 2008, BMC Genomics.
[25] S. Octavia,et al. Single-Nucleotide-Polymorphism Typing and Genetic Relationships of Salmonella enterica Serovar Typhi Isolates , 2007, Journal of Clinical Microbiology.
[26] S. Levy,et al. Molecular Mechanisms of Antibacterial Multidrug Resistance , 2007, Cell.
[27] Lars Jelsbak,et al. Molecular Epidemiology and Dynamics of Pseudomonas aeruginosa Populations in Lungs of Cystic Fibrosis Patients , 2007, Infection and Immunity.
[28] Yehuda Carmeli,et al. Multidrug-Resistant Pseudomonas aeruginosa: Risk Factors and Clinical Impact , 2006, Antimicrobial Agents and Chemotherapy.
[29] K. Poole. Efflux-mediated antimicrobial resistance. , 2005, The Journal of antimicrobial chemotherapy.
[30] C. Bailly,et al. Role of the Multidrug Efflux System MexXY in the Emergence of Moderate Resistance to Aminoglycosides among Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis , 2004, Antimicrobial Agents and Chemotherapy.
[31] Angela Lee,et al. MexXY-OprM Efflux Pump Is Necessary for Adaptive Resistance of Pseudomonas aeruginosa to Aminoglycosides , 2003, Antimicrobial Agents and Chemotherapy.
[32] H. Nikaido,et al. Contributions of MexAB-OprM and an EmrE Homolog to Intrinsic Resistance of Pseudomonas aeruginosa to Aminoglycosides and Dyes , 2003, Antimicrobial Agents and Chemotherapy.
[33] K. Poole. Outer membranes and efflux: the path to multidrug resistance in Gram-negative bacteria. , 2002, Current pharmaceutical biotechnology.
[34] L. Lerner-Geva,et al. Pseudomonas aeruginosa bacteremia in children: analysis of trends in prevalence, antibiotic resistance and prognostic factors , 2000, The Pediatric infectious disease journal.
[35] M. Jesudason,et al. E test as an alternative to conventional MIC determination for surveillance of drug resistant Streptococcus pneumoniae. , 1997, The Indian journal of medical research.
[36] Thomas L. Madden,et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.
[37] M. Metzker. Sequencing technologies — the next generation , 2010, Nature Reviews Genetics.
[38] C Kelly,et al. BULLETIN EUROPÉEN SUR LES MALADIES TRANSMISSIBLES / EUROPEAN COMMUNICABLE DISEASE BULLETIN , 2003 .
[39] Michael J. McGuffin,et al. BIOINFORMATICS APPLICATIONS NOTE , 2022 .
[40] M. Pallen,et al. Outbreaks: Defi Nition and Classifi Cation Genomics and Outbreak Investigation: from Sequence to Consequence , 2022 .